↓ Skip to main content

Biology-driven cancer drug development: back to the future

Overview of attention for article published in BMC Biology, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

1 blog


37 Dimensions

Readers on

128 Mendeley
11 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Biology-driven cancer drug development: back to the future
Published in
BMC Biology, April 2010
DOI 10.1186/1741-7007-8-38
Pubmed ID

Christopher J Lord, Alan Ashworth


Most of the significant recent advances in cancer treatment have been based on the great strides that have been made in our understanding of the underlying biology of the disease. Nevertheless, the exploitation of biological insight in the oncology clinic has been haphazard and we believe that this needs to be enhanced and optimized if patients are to receive maximum benefit. Here, we discuss how research has driven cancer drug development in the past and describe how recent advances in biology, technology, our conceptual understanding of cell networks and removal of some roadblocks may facilitate therapeutic advances in the (hopefully) near future.

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 3%
France 2 2%
Germany 2 2%
United States 2 2%
Malaysia 1 <1%
Slovenia 1 <1%
South Africa 1 <1%
Spain 1 <1%
Argentina 1 <1%
Other 0 0%
Unknown 113 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 40 31%
Student > Ph. D. Student 18 14%
Student > Bachelor 12 9%
Professor 11 9%
Other 9 7%
Other 28 22%
Unknown 10 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 57 45%
Medicine and Dentistry 27 21%
Biochemistry, Genetics and Molecular Biology 14 11%
Chemistry 7 5%
Computer Science 4 3%
Other 7 5%
Unknown 12 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2010.
All research outputs
of 17,351,915 outputs
Outputs from BMC Biology
of 1,498 outputs
Outputs of similar age
of 161,839 outputs
Outputs of similar age from BMC Biology
of 1 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,498 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.6. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,839 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them